1. Home
  2. CALC vs GFAI Comparison

CALC vs GFAI Comparison

Compare CALC & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$1.08

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

BUY

Current Price

$0.22

Market Cap

6.2M

ML Signal

BUY

Company Overview

Basic Information
Metric
CALC
GFAI
Founded
2011
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.2M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
CALC
GFAI
Price
$1.08
$0.22
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $38.00
N/A
AVG Volume (30 Days)
56.0K
★ 154.6K
Earning Date
11-11-2026
09-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.88
Revenue Next Year
N/A
$5.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$0.19
52 Week High
$72.00
$1.14

Technical Indicators

Market Signals
Indicator
CALC
GFAI
Relative Strength Index (RSI) 23.53 22.03
Support Level $0.44 N/A
Resistance Level $2.31 $0.41
Average True Range (ATR) 0.12 0.02
MACD 0.05 -0.01
Stochastic Oscillator 0.00 11.21

Price Performance

Historical Comparison
CALC
GFAI

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.

Share on Social Networks: